Sponsor Dossier
Medison Pharma
Sponsor Dossier for Medison Pharma. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
About
Medison Pharma is an Australian Private Company with ABN 19659723403, registered in New South Wales. The entity is active.
Portfolio
Medison Pharma has six brands on the ARTG, all of which are indexable. All six brands have Product Information on file, five brands are PBS-listed, six brands have PBAC outcomes on record, and five brands have AusPARs on record. Notable brands include AMVUTTRA, GIVLAARI, KIMMTRAK, LIBTAYO, ONPATTRO, and OXLUMO.
Therapeutic focus —
Oncology: 2 brands — Neurology: 1 brand — Gastroenterology: 1 brand — Immunology: 1 brand — Rare Disease: 1 brand
PBS footprint
Five of Medison Pharma's brands are PBS-listed, with the portfolio most recently touching the PBS schedule on 1 May 2026.
Regulatory activity
Medison Pharma's most recent PBAC outcome was recorded on 1 July 2025, with six brands holding PBAC outcomes on record. The most recent AusPAR was published on 20 June 2024, with five brands holding AusPARs on record.